Welcome to Phoenix Rising!
Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.
To become a member, simply click the Register button at the top right.
July 15, 2010The U.S. Centers for Disease Control and Prevention (CDC) named W. Ian Lipkin, MD, co-chair of its National Biosurveillance Advisory Subcommittee (NBAS). As the subcommittee to the CDC, NBAS provides counsel to the federal government on the broad range of issues impacting the development and implementation of a nationwide biosurveillance strategy for human health.
NBAS was established in May 2005, in response to the Homeland Security Presidential Directive recognizing the emergence of significant health-related threats to the nation, to "ensure that the Federal Government is meeting the goal of enabling state and local government public health surveillance capabilities."
Comprised of recognized experts in their fields that advise on key priority areas, the subcommittee is an innovative body for advancing nationwide biosurveillance capabilities. Serving as co-chair with Dr. Lipkin is Dr. Jeffrey Angle, state health director, North Carolina.
Dr. Lipkin, the John Snow Professor of Epidemiology, was selected co-chair by CDC Director Thomas Frieden, MD, MPH for his unique experience as director for the Mailman School of Public Health’s Center of Infection and Immunity. In particular, the CDC Advisory Committee cites his service as a Task Force Champion for NBAS, and his understanding of the importance of this subcommittee.
Dr. Lipkin’s work as a “microbe hunter” is at the frontiers of public health, creating and implementing state-of-the-art molecular tools in a global network to reduce the risks of acute and chronic diseases. His contributions include the first use of purely molecular methods to identify an infectious agent; implication of West Nile virus as the cause of the encephalitis in North America in 1999; first use of deep sequencing in pathogen discovery; and discovery of more than 200 viruses including rhinovirus C, Dandenong, and LuJo.
Dr. Lipkin served in Beijing as an intermediary between the WHO and the Chinese government during the SARS outbreak of 2003, and co-directed SARS research efforts in China with current Minister of Health Chen Zhu.
Over the course of his career, Dr. Lipkin has assisted the CDC, Chinese Ministry of Science and Technology, U.S. Department of Agriculture, and the U.S. Department of Defense in outbreaks of respiratory disease, hemorrhagic fever, meningoencephalitis, and vaccine safety investigations.
NBAS’ first report, "Improving the Nation's Ability to Detect and Respond to 21st Century Health Threats," was released in October 2009, and included five high-level, cross-cutting recommendations to be considered by federal leadership. This year the subcommittee's six task forces will undertake issues related to governance, healthcare and public health information, innovative information sources, biosurveillance collaboration, biosurveillance workforce, and integrated multi-sector information.
Aruschima - NBAS was established in May 2005, in response to the Homeland Security Presidential Directive recognizing the emergence of significant health-related threats to the nation, to "ensure that the Federal Government is meeting the goal of enabling state and local government public health surveillance capabilities."
Comprised of recognized experts in their fields that advise on key priority areas, the subcommittee is an innovative body for advancing nationwide biosurveillance capabilities.
Dr. Lipkin, the John Snow Professor of Epidemiology, was selected co-chair by CDC Director Thomas Frieden, MD, MPH for his unique experience as director for the Mailman School of Public Health’s Center of Infection and Immunity. In particular, the CDC Advisory Committee cites his service as a Task Force Champion for NBAS, and his understanding of the importance of this subcommittee.
So full of exciting advances for ME now Cort and delighted to see this one for our friends across the pond. Momentum gathering all round.
By the time they get through with all the personell changes here, the evidence is going to be so overwhelming it's likely to hit the UK like a tidal wave. (here's hopin' some folks just get wasssshhhhed away. Grins)
Cort, do you have any idea or have you read anything about how they will define their CFS/ME patient group?
I think this might be really important - patient selection. I'm just super curious how they will define and gather their CFS/M.E. cohort.
any other info from the XMRV meeting at NIH today?Dr. W. Ian Lipkin Named the Co-Chair of CDCs National Biosurveillance Advisory Subcommittee
check out the date below: coincidence ?!
He Ladies and Germs, if little Ian Lipkin was playing the flute with Jethro Tull back in the day, then why the hell didn't little Stevie Ray Strauss and Tony "the screwup" Fauci put him on the trail of all the supposed NON Chronic Epstein barr Virus patients who couldn't get out of bed way back in the early to mid 1980's?. ms. Gidget Faubion amassed more than 400 support groups all across America from 1976 to 1987 or so, with NO Internet and quite expensive long distance phone calls. When i first collapsed in 1984, CEBV was getting all the press. If little Ian was the boy wonder back then, why wasn't he put on the case then? I don't get it...
July 15, 2010
I'm quickly trying to get up to speed on the day's events.
My question- Seeing as how this study is yet another replication study- does it put us any closer to clinical trials?
Actually after today I'm beginning to think more studies is the only way we are going to get to clinical trials...the research community needs to get how to find XMRV nailed down first - so this is part of that. The good news is that he seems to be so respected that if he can find it that will help calm the controversy considerably. I imagine that he's the kind of guy that could unlock the problems others are having as well.
I wonder if the study has started and when it is expected to end?